PharmaNet (2006) Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Gauting Germany (1996)
Status: Acquired by inVentiv (2011) → now Syneos Health (2017)

Organization Overview

First Clinical Trial
2003
NCT00158093
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

SFBC Ft. Myers, Inc | SFBCI | SFBC International | SFBC International, Inc. | SFBC International, SFBC Miami, Inc. 11190 Biscayne Blvd.Miami, Fl 33181, USA

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: PharmaNet (2006) (0) Acquired (1)

idursulfase (elaprase) (1 trial)

Drugs in Phase 3 Trials (1)

Key: PharmaNet (2006) (0) Acquired (1)

testosterone (delatestryl) (1 trial)

Drugs in Phase 2 Trials (2)

Key: PharmaNet (2006) (0) Acquired (2)

corticorelin ovine triflutate (acthrel) (1 trial)

drl-17822 (1 trial)

Drugs in Phase 1 Trials (15)

Key: PharmaNet (2006) (13) Acquired (2)

antroquinonol (1 trial)

atenolol (tenormin) (1 trial)

bupropion (wellbutrin) (5 trials)

Cetilistat (oblean) (1 trial)

cyclobenzaprine (flexeril) (4 trials)

desloratadine (clarinex) (2 trials)

estradiol (progynon depot) (1 trial)

letrozole (femara) (2 trials)

megestrol (megace) (1 trial)

moxifloxacin (avelox) (1 trial)

nateglinide (starlix) (2 trials)

nebivolol (bystolic) (1 trial)

tranylcypromine (parnate) (1 trial)

ziprasidone (geodon) (2 trials)

zonisamide (Zonegran) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 1)

Malnutrition (Phase 1)

Obesity (Phase 1)

Renal Insufficiency (Phase 1)

Tissue Adhesions (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 29
  • # of Trial APIs: 19